DrugNews Notes Possible Pradaxa Bleeding Antidote as Lawsuits Rise

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Anyone who suffered internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options.

Chicago, IL (PRWEB) April 08, 2014

The prescription drug safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. As the number of lawsuits alleging the drug caused internal bleeding continue to rise, researchers have reported a possible antidote*.

DrugNews is a free resource providing the latest recalls, safety alerts, research and legal news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.

Pradaxa was approved by the FDA in 2010 to prevent blood clots and strokes in patients with atrial fibrillation. Experts disagree, however, whether it increases risks of internal bleeding.

DrugNews has added research suggesting patients taking newer blood thinners like dabigatran may be 55% more likely to suffer internal bleeding**. The Institute for Safe Medication Practices has also advised bleeding from Pradaxa could be 5 times as likely to cause death***.

Due to the number of families that have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated in a special federal multidistrict litigation court. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

The latest report from the Judicial Panel on Multidistrict Litigation shows the number of lawsuits filed has risen over 4% in less than a month, from 2,139 in February to 2,226 as of March 13th****.

Now, DrugNews has learned of a new study presented at last month’s American College of Cardiology session suggesting researchers may have discovered an antidote to help with Pradaxa bleeding* The drug, called aDabi-Fab, produced substantially fewer bleeding events when tested on animals given dabigatran*

Anyone who suffered internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*American College of Cardiology 2014; abstractsonline.com/pp8/#!/3392/presentation/44019
**Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****JPML, 3/13/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-March-13-2014.pdf


Contact